Rich Kalman
richkalman.bsky.social
Rich Kalman
@richkalman.bsky.social
Is there still a role for regorafenib in the management of HCC in 2025 ? So many options, but this humble TKI may still have a role.

#LiverSky #Gastrosky #OncSky

www.dovepress.com/tolerability...
Tolerability and Effectiveness of Regorafenib Treatment in Patients wi | JHC
Describing the safety and effectiveness of regorafenib among the United States subset of patients in the REFINE study relative to patients in the non-US sub
www.dovepress.com
February 22, 2025 at 3:22 PM